These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 26979597)
1. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells. Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597 [TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs. Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969 [TBL] [Abstract][Full Text] [Related]
3. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers. Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259 [TBL] [Abstract][Full Text] [Related]
4. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts. Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704 [TBL] [Abstract][Full Text] [Related]
5. Ultra-High-Frequency Reprogramming of Individual Long-Term Hematopoietic Stem Cells Yields Low Somatic Variant Induced Pluripotent Stem Cells. Wang K; Guzman AK; Yan Z; Zhang S; Hu MY; Hamaneh MB; Yu YK; Tolu S; Zhang J; Kanavy HE; Ye K; Bartholdy B; Bouhassira EE Cell Rep; 2019 Mar; 26(10):2580-2592.e7. PubMed ID: 30840883 [TBL] [Abstract][Full Text] [Related]
6. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming. Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499 [TBL] [Abstract][Full Text] [Related]
7. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy. Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904 [TBL] [Abstract][Full Text] [Related]
8. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells. Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802 [TBL] [Abstract][Full Text] [Related]
9. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs. Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169 [TBL] [Abstract][Full Text] [Related]
10. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts. Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015 [TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator. Ferreira AF; Calin GA; Picanço-Castro V; Kashima S; Covas DT; de Castro FA J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29467236 [TBL] [Abstract][Full Text] [Related]
12. Derivation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells. Sugimura R Methods Mol Biol; 2019; 2005():37-41. PubMed ID: 31175644 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide mapping of miRNAs expressed in embryonic stem cells and pluripotent stem cells generated by different reprogramming strategies. Zhao B; Yang D; Jiang J; Li J; Fan C; Huang M; Fan Y; Jin Y; Jin Y BMC Genomics; 2014 Jun; 15(1):488. PubMed ID: 24942538 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation. Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367 [TBL] [Abstract][Full Text] [Related]
15. Global epigenetic changes during somatic cell reprogramming to iPS cells. Mattout A; Biran A; Meshorer E J Mol Cell Biol; 2011 Dec; 3(6):341-50. PubMed ID: 22044880 [TBL] [Abstract][Full Text] [Related]
16. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage. Jackson SA; Olufs ZP; Tran KA; Zaidan NZ; Sridharan R Stem Cell Reports; 2016 Mar; 6(3):302-11. PubMed ID: 26905202 [TBL] [Abstract][Full Text] [Related]
17. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs. Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677 [TBL] [Abstract][Full Text] [Related]
18. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming. Kang L; Wu J; Tao Y; Li H; Liu X; Gao S; Wang QF Stem Cells Dev; 2015 Jun; 24(12):1483-92. PubMed ID: 25751301 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells. Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788 [TBL] [Abstract][Full Text] [Related]
20. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations. Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]